Skip to main content
TipRanks
Go Ultimate75% OFF

Cannabix Technologies (8CT) Stock Price & Analysis

0 Followers

8CT Stock Chart & Stats

€0.23-€0.03(-4.88%)
At close: 5:30 PM GMT+1
€0.26€0.27€0.28€0.29Sep 17Oct 23Nov 9
Day’s Range
EUR 0.23 - EUR 0.23
52-Week Range
EUR 0.18 - EUR 0.55
Previous Close
EUR 0.25
Volume
N/A
Average Volume (3M)
2,547
Market Cap
EUR 27.27M
Enterprise Value
EUR 61.64M
Total Cash (Recent Filing)
EUR 1.13M
Total Debt (Recent Filing)
EUR 125.08K
Price to Earnings (P/E)
―
Beta
-0.79
Next Earnings
Dec 18, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Very low leverage reduces solvency pressure and leaves the company less exposed to interest obligations than a highly indebted peer. Although the capital base is weakening, modest debt gives management more flexibility to fund development without immediate balance-sheet strain.

Multiple Commercial Use Cases

The company is pursuing several institutional applications for its breath-analysis technology rather than relying on one narrowly defined customer segment. If development succeeds, this use-case breadth could support multiple routes to adoption across regulated testing and public-safety markets.

Lower Operating Cash Burn

Operating cash outflow has moderated compared with 2024, indicating some improvement in the pace at which the business consumes funds. The company remains cash-flow negative, but sustained cost discipline could extend funding runway while its technology and workflows continue developing.

Bears Say

Absent Revenue Base

The lack of meaningful reported revenue indicates that commercialization has not yet produced a dependable operating base. Without recurring sales, the company has limited internal funding capacity and remains highly dependent on successful product development and future external financing.

Persistent And Volatile Losses

Large and recurring net losses show that the current business model is not yet economically self-sustaining. The deterioration from 2023 to 2026 annual also demonstrates earnings volatility, making it harder to establish a durable profitability trajectory over the next several quarters.

Cash Burn And Capital Erosion

Sustained negative operating and free cash flow requires ongoing funding, while the sharp decline in shareholders' equity shows that losses are consuming the capital base. This combination can restrict investment capacity and increase reliance on future capital raising to maintain operations.

Cannabix Technologies News

8CT FAQ

What was Cannabix Technologies’s price range in the past 12 months?
Cannabix Technologies lowest stock price was €0.18 and its highest was €0.55 in the past 12 months.
What is Cannabix Technologies’s market cap?
Cannabix Technologies’s market cap is €27.27M.
When is Cannabix Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cannabix Technologies’s earnings last quarter?
Cannabix Technologies released its earnings results on Aug 29, 2026. The company reported -€0.003 earnings per share for the quarter.
Is Cannabix Technologies overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Cannabix Technologies pay dividends?
Cannabix Technologies does not currently pay dividends.
What is Cannabix Technologies’s EPS estimate?
Cannabix Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannabix Technologies have?
Cannabix Technologies has 123,177,765 shares outstanding.
What happened to Cannabix Technologies’s price movement after its last earnings report?
Cannabix Technologies reported an EPS of -€0.003 in its last earnings report. Following the earnings report the stock price went down -1.739%.
Which hedge fund is a major shareholder of Cannabix Technologies?
Currently, no hedge funds are holding shares in DE:8CT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology